Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse

Drug Testing and Analysis

Volumn 6, Issue 5, 2014, Pages 492-499

  Beck, Olof ^a   Rausberg, Linnea ^a   Al Saffar, Yasir ^a   Villen, Tomas ^a   Karlsson, Lennart ^b   Hansson, Therese ^c   Helander, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

CEDIA; Drug screening; Drug testing; EMIT; Immunoassay; KIMS; New psychoactive substances; Urine

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; IMMUNOLOGY; LABORATORIES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

CEDIA; CROSS-REACTIVITY; DRUG OF ABUSE; DRUG TESTING; DRUG-SCREENING; EMIT; IMMUNOASSAY; KIMS; NEW PSYCHOACTIVE SUBSTANCE; URINE;

SCREENING;

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; COCAINE; PHENCYCLIDINE DERIVATIVE; PSYCHOTROPIC AGENT;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; CROSS REACTION; DRUG ABUSE; DRUG INTOXICATION; DRUG SCREENING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; IMMUNOCHEMISTRY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS; HUMAN; IMMUNOASSAY; IMMUNOLOGY; PROCEDURES; SUBSTANCE ABUSE; URINE;

CROSS REACTIONS; HUMANS; IMMUNOASSAY; PSYCHOTROPIC DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 84899977106     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1641     Document Type: Article

References (20)

1. EMCDDA. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2013. Available at: www.emcdda.europa.eu [10 March 2014]
2. J.O. Thörngren, F. Östervall, M. Garle . A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS. J. Mass Spectrom. 2008, 43, 980.
3. J.J. Pitt . Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. Clin. Biochem. Rev. 2009, 30, 19.
4. H.K. Lee, C.S. Ho, Y.P.H. Iu, P.S.J. Lai, C.C. Shek, Y.-C. Lo, H.B. Klinke, M. Wood . Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of flight mass spectrometry. Anal. Chim. Acta 2009, 649, 80.
5. H.H. Maurer . Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther. Drug Monit. 2010, 32, 324.
6. F.T. Peters . Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin. Biochem. 2011, 44, 54.
7. I. Ojanperä, M. Kolmonen, A. Pelander . Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal. Bioanal. Chem. 2012, 403, 1203.
8. M.D. Krasowski, A.F. Pizon, M.G. Siam, S. Giannoutsos, M. Iyer, S. Ekins . Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. BMC Emerg. Med. 2009, 9, 5.
9. J. Hsu, C. Liu, C.P. Hsu, W.I. Tsay, J.H. Li, D.L. Lin, R.H. Liu . Performance characteristics of selected immunoassays for preliminary test of 3, 4-methylenedioxymethamphjetamine, methamphetamine, and related drugs in urine specimens. J. Anal. Toxicol. 2003, 27, 471.
10. L.G. Apollonio, I.R. Whittall, D.J. Pianca, J.M. Kyd, W.A. Haher . Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using Bio-Quant direct Elisa ptresumptive assays for amphetamine and methamphetamine. J. Anal. Toxicol. 2007, 31, 208.
11. S. Kerrigan, M. Brady Mellon, S. Banuelos, C. Arndt . Evaluation of commercial enzyme-linked immuno assays to identify psychedelic phenethylamines. J. Anal. Toxicol. 2011, 35, 444.
12. C. Bell, C. George, A.T. Kicman, A. Traynor . Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test. Anal. 2011, 3, 496.
13. A.M. Macher, T.M. Penders . False-positive phencyclidine immunoassay results caused by 3, 4-methylenedioxypyrovalerone (MDPV). Drug Test. Anal. 2012, 5, 130.
14. K. Nakanishi, A. Miki, K. Zaitsu, H. Kamata, N. Shimas, T. Kamata, M. Katagi, M. Tatsuno, H. Tsuchihashi, K. Suzuki . Cross-reactivity of various phenethylamine-type drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine test Instant-View™, and the EMIT® assays for use in drug enforcement. Forensic Sci. Int. 2012, 217, 174.
15. M. Petrie, K.L. Lynch, S. Ekins, J.S. Chang, R.J. Goetz, A.H.B. Wu, M.D. Krasowski . Cross-reactivity studies and predictive modeling of 'Bath Salts' and other amphetamine-type stimulants with amphetamine screening immunoassays. Clin. Toxicol. 2013, 51, 83.
16. Y. Al-Saffar, N.N. Stephanson, O. Beck . Multicomponent LC-MS/MS screening method for detrection of new psychoactive drugs, legal highs, in urine - experience from the Swedish population. J. Chromatogr. B 2013, 930, 112.
17. A. Helander, O. Beck, R. Hägerkvist, P. Hulten . Identification of novel psychoactive drug use in Sweden based on laboratory analysis-initial experiences from the STRIDA project. Scand. J. Clin. Lab. Inv. 2013, 73, 400.
18. E. Bertol, F. Vaiano, S. Fulanetto, F. Mari . Cross-reactivities and structure-reactivity relationships of six benzodiazepines to EMIT immunoassay. J. Pharmaceut. Biomed. 2013, 84, 168.
19. E. Bertol, F. Vaiano, M. Borsotti, M. Quercioli, F. Mari . Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: Results of a national proficiency test. J. Anal. Toxicol. 2013, 37, 659.
20. A. Arntson, B. Ofsa, D. Lancaster, J.R. Simon, M. McMullin, B. Logan . Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J. Anal. Toxicol. 2013, 37, 284.